What does TetraLogic Pharmaceuticals Corporation do?

TetraLogic Pharmaceuticals Corporation (TLOG) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is TLOG's market cap?

TetraLogic Pharmaceuticals Corporation (TLOG) has a market capitalization of approximately $979, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does TLOG pay a dividend?

No — TetraLogic Pharmaceuticals Corporation (TLOG) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

TetraLogic Pharmaceuticals Corporation (TLOG) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

TLOG

TetraLogic Pharmaceuticals Corporation

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$979.00·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.67%CAGR −68.18%

Select date range

FromTo

Dec 12, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

TLOG does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateFeb 28

Last Report DateNov 3

Reported vs Estimate−$0.08

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$45.76M

Net Margin—

Operating Cash Flow−$23.88M

Capital Expenditures$666.00

Free Cash Flow−$23.88M

Return on Equity—

Return on Invested Capital−24.7%

Net Debt$24.92M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for TLOG and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how TLOG's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TLOG and 80,000+ other tickers.

About TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical…

CEO: Yigong Shi
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 29
Website: www.tetralogicpharma.com

Peers

Peers Tab

ARNI

Arno Therapeutics, Inc.

Cap

$4.9K

CALA

Calithera Biosciences, Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About TLOG

What does TetraLogic Pharmaceuticals Corporation do?: TetraLogic Pharmaceuticals Corporation (TLOG) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is TLOG's market cap?: TetraLogic Pharmaceuticals Corporation (TLOG) has a market capitalization of approximately $979, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does TLOG pay a dividend?: No — TetraLogic Pharmaceuticals Corporation (TLOG) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is TLOG profitable?: TetraLogic Pharmaceuticals Corporation (TLOG) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.